Quipt Home Medical (QIPT.V)

Chronic care, ventilators. Revenue growing at a fantastic rate, using a subscription model. Cheap compared to peers. Not a concern whether Medicare or Medicaid are cut. Perfect example of money rotation to small caps. Management owns a fairly good position. No dividend. (Analysts’ price target is $121.37)

(A Top Pick Jul 02/20, Up 72%) A US medical device company (lifts, oxyegen and other homecare products). Continues to like it, given aging demographics. The valuation is attractive. They continue to grow by acqusition, adding geographic regions and fragmented, small busineses. They have cash to buy more companies and are EBIDTA positive. Good cash flow. Expects this to get taken out one day. Price pressures are always a possibility if suppliers raise prices. Also there are reimbursement cuts in the U.S. medical system every few years, another caveat.